Learning Point:

Cost is a health economics component of PICO. In Mrs. Rahma's current clinical context, the main priority is Clinical Efficacy. An inexpensive drug is meaningless if it provides no therapeutic effect (is ineffective).

Map: The Knee (1113)
Node: 21043
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway